Brief: PledPharma Q2 Net Loss Widens To SEK 36.2 Million
Aug 20 (Reuters) - PledPharma AB (publ) PLED.ST :
* Q2 NET SALES SEK 21.7 MILLION VERSUS SEK 5.0 MILLION YEAR
AGO
* Q2 NET LOSS SEK 36.2 MILLION VERSUS LOSS SEK 29.4 MILLION
YEAR
AGO
Source text for Eikon: ID:nNDL6TFnZX
Further company coverage: PLED.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1